From GlobeNewswire:

Microbot Medical, developer of the LIBERTY Endovascular Robotic Surgical System, settled a lawsuit filed in 2020 with Empery Asset Master Ltd., Empery Tax Efficient, LP, and others. The settlement’s cost will not affect the company’s cash position thanks to insurance coverage. CEO Harel Gadot says the settlement allows Micrbot to maintain focus on upcoming milestones including FDA submissions and clinical trials. Microbot Medical Inc. (NASDAQ: MBOT) specializes in micro-robotic technology to improve clinical outcomes and provide greater access to endoral and artificial lumens within the human body. Details can be found at http://www.microbotmedical.com.



Read more: Microbot Medical Announces Settlement and Release